IP Library Granted Patent US 11,944,535
Granted Patent B2
US 11,944,535 · App. 17/663,748 · Granted Apr 2, 2024

Intraocular lenses having zone-by-zone step height control

Inventors: Xin Hong (Fort Worth, TX); Shinwook Lee (Arlington, TX)
Assignee: Alcon Inc.
A61F2/1656A61F2/1616A61F2/1618A61F2/1654G02B3/08G02B27/0012G02B27/4205G02C7/04G02C7/044A61F2002/1683G02C2202/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,944,535
App. No.
17/663,748
Granted
Apr 2, 2024
Kind
B2
Abstract

A method and system provide an ophthalmic device. The ophthalmic device includes an ophthalmic lens having anterior surface, a posterior surface and at least one diffractive structure including a plurality of zones. The at least one diffractive structure is for at least one of the anterior surface and the posterior surface. Each zone includes at least one echelette having a least one step height. The step height(s) are individually optimized for each zone. To compensate chromatic aberration of eye from distance to a range of vision, a greater than 2π phase step height may be employed and the step height(s) folded by a phase, which is an integer multiple of two multiplied by π. Hence chromatic aberration of eye may be compensated to improve vision from distance to near.

Claims (14)

1. An intraocular lens (IOL) having at least one focal length, the intraocular lens comprising:

an anterior surface;

a posterior surface; and

at least one diffractive structure including a plurality of zones, each of the plurality of zones including at least one echelette having at least one step height, the at least one step height being individually determined and optimized for each zone of the plurality of zones;

wherein a particular echelette in a particular one of the plurality of zones has an optimized step height that exceeds 2π and the diffractive structure includes a first echelette and a second echelette to represent the particular echelette, the first echelette having a step height of 2π and the second echelette having a step height of the difference between the optimized step height and 2π,

wherein the difference between the optimized step height and 2π is achieved by folding the optimized step height by a phase,

wherein, after folding the optimized step height by a phase, the step height of the second echelette is not more than two multiplied by π,

wherein the optimized step height and the folding by a phase compensates for chromatic aberration for a range of vision,

wherein the at least one focal length includes a plurality of focal lengths such that the intraocular lens is a multifocal IOL.

2. The intraocular lens of claim 1 wherein each zone is individually optimized for a portion of the plurality of focal lengths.

3. The intraocular lens of claim 1 wherein each zone is individually optimized for the plurality of focal lengths.

4. The intraocular lens of claim 1 wherein the at least one step height includes a plurality of step heights.

5. The intraocular lens of claim 1 wherein the at least one diffractive structure is incorporated into the anterior surface.

6. The intraocular lens of claim 1 wherein each zone is individually optimized for a plurality of target positions.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: HONG, XIN; LEE, SHINWOOK
To: ALCON RESEARCH, LTD.
Reel/Frame 060320/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 060320/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: HONG, XIN; LEE, SHINWOOK
To: ALCON RESEARCH, LTD.
Reel/Frame 060320/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 060320/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 060320/0385 →
Continuity (4)
Continuation 17073896 · Oct 19, 2020
Division 15807771 · Nov 9, 2017
Provisional Application 62427241 · Nov 29, 2016
Related Publication 20220273424A1 · Sep 1, 2022